Boston An independent LDT provider

Press releases

November 2, 2020 | REGULATORY

Immunovia Provides Complementary Details on the IMMray[™] PanCan-d Verification Study

Read press release
October 30, 2020 | REGULATORY

Change in the Number of Shares and Votes in Immunovia AB (publ)

Read press release
October 26, 2020 | REGULATORY

Immunovia Announces Completion of Analysis from the IMMray[™] PanCan-d Verification Study

Read press release
September 29, 2020 | REGULATORY

Immunovia Announces Positive Results from the IMMray[™] PanCan-d Verification Study

Read press release
September 2, 2020 | REGULATORY

Immunovia Announces Management Team Changes

Read press release
August 31, 2020 | REGULATORY

NOTICE OF EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB

Read press release
August 26, 2020 | REGULATORY

Immunovia Announces CEO Transition: Appoints Patrik Dahlen as New CEO

Read press release
August 20, 2020 | REGULATORY

Immunovia Reports Second Quarter Interim Report January – June 2020

Read press release
June 30, 2020 | REGULATORY

Change in the number of shares and votes in Immunovia AB (publ)

Read press release
June 30, 2020 | REGULATORY

Immunovia Targeting Long-Term Market Penetration of 30% for IMMray™ PanCan-d

Read press release
June 26, 2020 | REGULATORY

Immunovia Expands its Lung Cancer Program Based on Encouraging Results from the Current Discovery Study

Read press release
June 9, 2020 | REGULATORY

Immunovia raised ~ 400m SEK to Further Accelerate the Market Introduction of the First Test for Early Detection of Pancreatic Cancer, the IMMray[™] PanCan-d

Read press release
1 2 3 4 5 13